Microglia and/or astrocytes play a significant role in the creation and maintenance of exaggerated pain states with inflammatory and/or neuropathic etiologies. The chemokine, fractalkine, has several functions, including the newly recognized role of mediating neuropathic pain conditions. Although constitutively expressed and released during inflammation, increased release of fractalkine binds to and activates microglia leading to pathological pain. We review the critical role of fractalkine in neuron-to-glial communication after peripheral nerve injury and inflammation and explore anti-inflammatory cytokines like interleukin-10 as a novel and effective approach for clinical pain control.
Previously understood views of pain
Traditionally, our understanding about neuronal signaling for pain transmission from the body to the central nervous system (CNS) occurs as a series of relay signals that are eventually processed in the brain. These relay signals are thought to serve protective and adaptive roles, with the first synaptic relay, between the first order (sensory) neuron and the second order neuron in the dorsal horn of the spinal cord. Neurons that receive and respond to pain information are primarily located in anatomically discrete regions of the spinal cord, that is, laminae I, II and V of the spinal cord dorsal horns. From the spinal cord dorsal horn, pain projection neurons relay their information to higher pain centers, such as to the brainstem and various relevant pain areas in the brain. Interestingly, the dorsal horn of the spinal cord can strongly modulate pain signaling (Millan, 1999) . Although the neuronal functioning of these pain pathways has been examined for decades, the induction and maintenance of non-adaptive, pathological pain is poorly understood. However, since the early 1990s, there has been mounting evidence that glial cells (both astrocytes and microglia), in addition to neurons, also play a critical role in pain modulation (Deleo et al., 2007) .
Glial modulation of neuronal activity
Glia act to dynamically regulate neuronal synaptic communication (Haydon, 2001) , and can lead to pathological pain via the release of a variety of neurotransmitters, neuromodulators (McMahon et al., 2005) , proinflammatory cytokines and chemokines (Rostene et al., 2007) . Astrocytes are closely associated with neuronal somas, dendrites, and pre-and postsynaptic sites, as well as with other glia (microglia), and their functions are now understood to include active, integrative roles during synaptic transmission (Fellin et al., 2006; Haydon, 2001) . The intimate contact astrocytes have with neurons can lead to enhanced synaptic transmission. A variety of functional neurotransmitter receptors, which include ionotropic non-NMDA and NMDA receptors (Porter and McCarthy, 1997; Schipke et al., 2001; Seifert and Steinhauser, 2001) , as well as metabotropic glutamate (mGluR3 and mGluR5), purinergic, and substance P receptors (Porter and McCarthy, 1997) are expressed on astrocytes and neurons. Glial activation can be
